Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Interim Management Statement

19 Apr 2013 15:36

RNS Number : 8213C
Maven Income and Growth VCT 5 PLC
19 April 2013
 

Interim Management Statement

 

Maven Income and Growth VCT 5 PLC (the Company) - quarter ended 28 February 2013

 

This Interim Management Statement, for the quarter ended 28 February 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 March 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

·; Net Asset Value (NAV)1 of 34.09p per share at 28 February 2013, compared to 32.08p per share at 30 November 2012;

·; NAV total return2 of 57.59p at 28 February 2013, compared to 55.58p at 30 November 2012; and

·; Final dividend of 1.15p per share in respect of the year ended 30 November 2012, to be paid on 24 May 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 28 February 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 November 2012, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 28 February 2013: a total of £850,000 was invested in four private companies; aggregate proceeds of £1,365,770 were realised from the disposal of eight AIM quoted investments against a total cost of £702,634; and a net £697,738 was invested in short-dated UK government securities.

 

3.

Recent developments

 

Between 1 March 2013 and the date of this Statement: £625,200 was invested in one private company; the disposal of shares in six AIM quoted investments realised aggregate proceeds of £581,798 against cost of £304,509; and a net £1,697,979 was invested in short-dated UK government securities.

 

At the Annual General Meeting of the Company, held on 16 April 2013, all Resolutions put to the Meeting were passed by the requisite majority.

 

Other than as described above and changes in the value of investments quoted on regulated markets, the Board is not aware of any events during the period from 1 December 2012 to 28 February 2013, or in the period from 1 March 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

19 April 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZKLFFXZFXBBE
Date   Source Headline
27th Feb 20203:04 pmRNSTransaction in Own Shares
24th Feb 20203:55 pmRNSTransaction in Own Shares
19th Feb 20204:30 pmRNSTransaction in Own Shares
18th Feb 202011:35 amRNSNet Asset Value and Proposed Final Dividend
28th Jan 20204:53 pmRNSDirectorate Change and Appointment of New Chairman
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20192:06 pmRNSTransaction in Own Shares
7th Oct 20194:22 pmRNSTransaction in Own Shares
3rd Oct 20192:34 pmRNSNet Asset Value(s)
2nd Sep 20193:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:28 pmRNSIssue of Equity
30th Aug 20194:29 pmRNSNet Asset Value(s)
27th Aug 20192:55 pmRNSTransaction in Own Shares
31st Jul 20192:16 pmRNSTransaction in Own Shares
18th Jul 20195:05 pmRNSHalf-year Report
4th Jul 20193:29 pmRNSStatement re Net Asset Value and Interim Dividend
5th Jun 20194:15 pmRNSDirectorate Change
14th May 20192:01 pmRNSTransaction in Own Shares
30th Apr 20191:06 pmRNSResult of AGM
24th Apr 20199:50 amRNSIssue of Equity
4th Apr 20192:16 pmRNSHolding(s) in Company
4th Apr 201911:01 amRNSIssue of Equity - Replacement
4th Apr 20199:17 amRNSIssue of Equity
25th Mar 20194:09 pmRNSStatement re Offer for Subscription
13th Mar 201912:12 pmRNSTransaction in Own Shares
7th Mar 20195:50 pmRNSIssue of Equity
4th Mar 201912:40 pmRNSNet Asset Value(s)
28th Feb 20195:42 pmRNSAnnual Financial Report
20th Feb 201912:30 pmRNSStatement re Offer for Subscription
15th Jan 20194:17 pmRNSTransaction in Own Shares
11th Jan 20193:50 pmRNSHolding(s) in Company
21st Dec 20181:00 pmRNSDirector/PDMR Shareholding
21st Dec 201810:39 amRNSIssue of Equity
18th Dec 20184:17 pmRNSNet Asset Value
5th Nov 20184:52 pmRNSTransaction in Own Shares
2nd Nov 201811:38 amRNSResult of General Meeting
10th Oct 20185:06 pmRNSTransaction in Own Shares
8th Oct 20184:48 pmRNSTransaction in Own Shares
5th Oct 20184:04 pmRNSTransaction in Own Shares
4th Oct 20183:03 pmRNSTransaction in Own Shares
3rd Oct 20187:00 amRNSNet Asset Value(s)
26th Sep 20186:29 pmRNSStatement re Offer for Subscription
24th Jul 20184:58 pmRNSTransaction in Own Shares
20th Jul 20182:56 pmRNSHalf-year Report
18th Jul 20189:21 amRNSNet Asset Value(s)
18th Jul 20187:00 amRNSStatement re Offer for Subscription
2nd May 20184:59 pmRNSHolding(s) in Company
25th Apr 20184:39 pmRNSNet Asset Value(s)
24th Apr 20181:34 pmRNSResult of AGM
12th Mar 20187:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.